Noncompaction cardiomyopathy embryology

Jump to navigation Jump to search

Noncompaction Cardiomyopathy Microchapters

Home

Patient Info

Overview

Historical Perspective

Classification & Nomenclature

Pathophysiology

Genetics
Embryology
Histology
Left Ventricular Dysfunction
Arrhythmias
Thromboembolism
Neuromuscular Disorders

Epidemiology & Demographics

Screening

Natural History, Complications & Prognosis

Differentiating Noncompaction Cardiomyopathy from other Diseases

Diagnosis

History & Symptoms

Physical Examination

Laboratory Studies

Genetic Testing

Electrocardiogram

Holter Monitoring

Chest X Ray

MRI

CT

Echocardiography

Biopsy

Treatment

Medical Therapy

Surgery

Noncompaction cardiomyopathy embryology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Noncompaction cardiomyopathy embryology

CDC on Noncompaction cardiomyopathy embryology

Noncompaction cardiomyopathy embryology in the news

Blogs on Noncompaction cardiomyopathy embryology

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Noncompaction cardiomyopathy embryology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Noncompaction results from the failure of heart muscle cells to transform from a spongy state to a compacted state during embryogenesis. The process can affect either the left or right ventricle, but generally affects on the left ventricle.

Embryonic Basis of Noncompaction

During development, the majority of the heart muscle is a sponge-like meshwork of interwoven myocardial fibers. As normal development progresses, these trabeculated structures undergo significant compaction that transforms them from spongy to solid. This process is particularly apparent in the [[ventricles of the heart|ventricles]], and particularly so in the left ventricle. Noncompaction cardiomyopathy results when there is failure of this process of compaction. Because the consequence of non-compaction is particularly evident in the left ventricle, the condition is also called left ventricular noncompaction. Less than half the patients with NCC have involvement of the right ventricle [1][2][3].

This abnormality in development begins to occur around the 8 week mark during fetal development. The myocardium at this period of development is often referred to as looking like a sponge as it is still a meshwork of interwoven myocardial fibers. This is beneficial at this stage as there is an increased surface area which allows perfusion of the myocardium from the left ventricular cavity. However as the embryo grows the myocardium should begin to be compact, in the case of NCC though the heart fails to fully compact leaving the myocardium to still have a spongy form. Non-compaction Cardiomyopathy can affect both ventricle walls of the heart separately or together. However, it generally affects only the left ventricle wall and therefore is sometimes known as left ventricular noncompaction.

Some authors have hypothesized that either myocardial ischemia or pressure overload may inhibit the regression of embryonic structures[4].

Some authors have challenged the hypothesis that NCC is due to an arrest in embryonic development. In one study, three infants who went on to develop NCC did not have the disease diagnosed at birth[5]. [6] It is unclear if limitations of fetal echocardiography may have played a role in failing to make the diagnosis at birth.

References

  1. Ritter M, Oechslin E, Sutsch G, et al. Isolated noncompaction of the myocardium in adults. Mayo Clin Proc. 1997; 72: 26–31.
  2. Zambrano E, Marshalko SJ, Jaffe CC, et al. Isolated noncompaction of the ventricular myocardium: clinical and molecular aspects of a rare cardiomyopathy. Lab Invest. 2002; 82: 117–122.
  3. Lauer RM, Fink HP, Petry EL, et al. Angiographic demonstration of intramyocardial sinusoids in pulmonary-valve atresia with intact ventricular septum and hypoplastic right ventricle. N Engl J Med. 1964; 271: 68–72.
  4. Oechslin EN, Attenhofer Jost CH, Rojas JR, et al. Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol. 2000; 36: 493–500.
  5. Stollberger C, Finsterer J, Blazek G. Left ventricular hypertrabeculation/noncompaction and association with additional cardiac abnormalities and neuromuscular disorders. Am J Cardiol. 2002; 90: 899–902.
  6. Bleyl SB, Mumford BR, Brown-Harrison MC, et al. Xq28-linked noncompaction of the ventricular myocardium: prenatal diagnosis and pathologic analysis of affected individuals. Am J Med Genet. 1997; 72: 257–265.


Template:WH Template:WS